rs1805247

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000834.5(GRIN2B):​c.4197T>C​(p.His1399His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.106 in 1,613,904 control chromosomes in the GnomAD database, including 12,512 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 3007 hom., cov: 33)
Exomes 𝑓: 0.10 ( 9505 hom. )

Consequence

GRIN2B
NM_000834.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: -0.0850

Publications

37 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 12-13563041-A-G is Benign according to our data. Variant chr12-13563041-A-G is described in ClinVar as Benign. ClinVar VariationId is 98432.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.085 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.329 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000834.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
NM_000834.5
MANE Select
c.4197T>Cp.His1399His
synonymous
Exon 14 of 14NP_000825.2Q13224
GRIN2B
NM_001413992.1
c.4197T>Cp.His1399His
synonymous
Exon 15 of 15NP_001400921.1A0A8D9PHB2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
ENST00000609686.4
TSL:1 MANE Select
c.4197T>Cp.His1399His
synonymous
Exon 14 of 14ENSP00000477455.1Q13224
GRIN2B
ENST00000630791.3
TSL:5
c.4197T>Cp.His1399His
synonymous
Exon 15 of 15ENSP00000486677.3A0A0D9SFK0
GRIN2B
ENST00000637214.1
TSL:5
c.69+45562T>C
intron
N/AENSP00000489997.1A0A1B0GU78

Frequencies

GnomAD3 genomes
AF:
0.166
AC:
25199
AN:
152054
Hom.:
2982
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.333
Gnomad AMI
AF:
0.120
Gnomad AMR
AF:
0.120
Gnomad ASJ
AF:
0.0845
Gnomad EAS
AF:
0.182
Gnomad SAS
AF:
0.213
Gnomad FIN
AF:
0.106
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0845
Gnomad OTH
AF:
0.154
GnomAD2 exomes
AF:
0.130
AC:
32584
AN:
251330
AF XY:
0.129
show subpopulations
Gnomad AFR exome
AF:
0.334
Gnomad AMR exome
AF:
0.117
Gnomad ASJ exome
AF:
0.0872
Gnomad EAS exome
AF:
0.168
Gnomad FIN exome
AF:
0.107
Gnomad NFE exome
AF:
0.0868
Gnomad OTH exome
AF:
0.107
GnomAD4 exome
AF:
0.0999
AC:
146040
AN:
1461732
Hom.:
9505
Cov.:
34
AF XY:
0.103
AC XY:
74824
AN XY:
727142
show subpopulations
African (AFR)
AF:
0.343
AC:
11494
AN:
33476
American (AMR)
AF:
0.117
AC:
5210
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0867
AC:
2265
AN:
26134
East Asian (EAS)
AF:
0.204
AC:
8112
AN:
39694
South Asian (SAS)
AF:
0.204
AC:
17616
AN:
86252
European-Finnish (FIN)
AF:
0.111
AC:
5908
AN:
53392
Middle Eastern (MID)
AF:
0.120
AC:
694
AN:
5768
European-Non Finnish (NFE)
AF:
0.0790
AC:
87872
AN:
1111910
Other (OTH)
AF:
0.114
AC:
6869
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
8210
16420
24630
32840
41050
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3422
6844
10266
13688
17110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.166
AC:
25263
AN:
152172
Hom.:
3007
Cov.:
33
AF XY:
0.166
AC XY:
12353
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.333
AC:
13835
AN:
41500
American (AMR)
AF:
0.120
AC:
1839
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0845
AC:
293
AN:
3466
East Asian (EAS)
AF:
0.182
AC:
936
AN:
5154
South Asian (SAS)
AF:
0.214
AC:
1029
AN:
4814
European-Finnish (FIN)
AF:
0.106
AC:
1120
AN:
10616
Middle Eastern (MID)
AF:
0.119
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
0.0845
AC:
5747
AN:
68006
Other (OTH)
AF:
0.152
AC:
320
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1003
2006
3009
4012
5015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
266
532
798
1064
1330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.113
Hom.:
2587
Bravo
AF:
0.173
Asia WGS
AF:
0.199
AC:
693
AN:
3478
EpiCase
AF:
0.0846
EpiControl
AF:
0.0799

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (4)
-
-
2
not specified (2)
-
-
1
Developmental and epileptic encephalopathy, 27 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Intellectual disability, autosomal dominant 6 (1)
-
-
1
Intellectual disability, autosomal dominant 6;C4015316:Developmental and epileptic encephalopathy, 27 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
2.2
DANN
Benign
0.51
PhyloP100
-0.085
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1805247; hg19: chr12-13715975; COSMIC: COSV74205188; COSMIC: COSV74205188; API